The Evolving Landscape of Coronary Artery Disease Drugs: From Statins to RNA-Targeted Therapies
The management of coronary artery disease (CAD) has undergone a remarkable transformation over the past decades. Once characterized by a limited arsenal of medications, the therapeutic landscape for this leading cause of global morbidity and mortality has expanded dramatically. Today, clinicians have a sophisticated array of coronary artery disease drugs at their disposal, ranging...
0 Commenti 0 condivisioni 117 Views 0 Anteprima